98%
921
2 minutes
20
Aim: We aimed to investigate the potential role of endothelin-1 (ET-1) in the regulation of the expression of α-smooth muscle actin (α-SMA) in human myometrial fibroblasts.
Methods: Primary myometrial fibroblasts were obtained from myometrium and were identified by immunocytochemical staining. Then, 1 × 10 cells were treated with ET-1 at a concentration of 0.1, 1.0, 10.0, or 100.0 nM for 24 h. To investigate the time course effects of ET-1 on the growth of fibroblasts, 1 × 10 cells were treated with 10.0 nM ET-1 for 6, 12, 24, and 48 h. Real-time quantitative PCR (qPCR) and Western blot analysis were used to determine the expression of α-SMA mRNA and protein, respectively.
Results: Human myometrial fibroblasts were identified by immunohistochemistry. Compared with the control group, the expression levels of α-SMA mRNA and protein were identified in cells treated with ET-1 at a concentration of 0.1, 1.0, 10.0, or 100.0 nM for 24 h (P < 0.05). ET-1 treatment affected the expression of α-SMA mRNA and protein in a dose-dependent manner (P < 0.05). The induction of α-SMA mRNA and protein expression increased from 6 to 48 h.
Conclusion: The results show that ET-1 induces the expression of α-SMA in human myometrium in vitro.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/jog.13539 | DOI Listing |
J Ultrasound Med
September 2025
Division of Gynecology and Human Reproduction Physiopathology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Objectives: Adenomyosis is challenging to diagnose with transvaginal ultrasound (TVUS) and requires operator expertise to recognize its sonographic features; however, little is known about the learning curve for trainees. This study aimed to assess the learning curve of inexperienced residents in diagnosing adenomyosis and identifying its key ultrasound signs using the learning curve-cumulative summation test (LC-CUSUM) method.
Methods: This prospective cohort study was conducted in 2 tertiary care centers specializing in endometriosis and adenomyosis.
NPJ Womens Health
February 2025
Department of Bioengineering, University of Washington, Seattle, WA, USA.
Approximately half of U.S. women giving birth annually receive Pitocin, a synthetic form of oxytocin (OXT), yet the optimal dosing remains challenging due to significant individual variability in response.
View Article and Find Full Text PDFCancer Rep (Hoboken)
September 2025
Department of Anesthesiology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Background: Postpartum placental choriocarcinoma is a rare gestational trophoblastic tumor, with an incidence of approximately one in 50 000. Patients often present with persistent postpartum hemorrhage, which can lead to delayed diagnosis, hematogenous metastasis, and ultimately, a poor prognosis.
Case: A 35-year-old woman was admitted to the Emergency Department 39 days after a cesarean section due to persistent heavy vaginal bleeding.
BMC Pregnancy Childbirth
August 2025
²Department of Obstetrics and Gynecology, Faculty of Medicine, Atatürk University, Erzurum, Turkey.
Background: This prospective clinical trial aimed to compare the effects of single-layer versus double-layer uterine closure techniques on cesarean scar healing in women undergoing repeat cesarean delivery.
Methods: Seventy women aged 18-50 years with a history of at least one prior cesarean delivery were randomized into two groups: single-layer non-locking closure (n = 35) and double-layer non-locking closure with surgical refreshing of the incision edges (n = 35). The primary outcome was residual myometrial thickness (RMT) measured by transvaginal ultrasonography at six months.
Mediators Inflamm
August 2025
KM Science Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea.
Primary dysmenorrhea (PD) is characterized by excessive uterine contraction and ischemic vasoconstriction, primarily driven by elevated levels of prostaglandins (PGs; PGF2α) and inflammatory mediators. Nonsteroidal antiinflammatory drugs (NSAIDs) remain the standard treatment for PD; however, their associated adverse effects necessitate the use of alternative therapeutic strategies. Maxim.
View Article and Find Full Text PDF